n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with luf 6000 in 1 studies
| Studies (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Trials (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Studies (luf 6000) | Trials (luf 6000) | Recent Studies (post-2010) (luf 6000) |
|---|---|---|---|---|---|
| 214 | 5 | 58 | 9 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Borea, PA; Preti, D; Varani, K | 1 |
1 review(s) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and luf 6000
| Article | Year |
|---|---|
Medicinal chemistry of A₃ adenosine receptor modulators: pharmacological activities and therapeutic implications.
Topics: Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; Chemistry, Pharmaceutical; Disease; Humans; Ligands; Receptor, Adenosine A3 | 2012 |